DALLAS, Nov. 27 /PRNewswire/ -- A new study that shows young women are dying of heart disease while the death rate for men has leveled off offers strong evidence that preventive medical care is the most effective solution to fighting the war on cardiovascular disease, said Christopher T. Fey, the chairman and CEO of U.S. Preventive Medicine(R).
The just released study published in Journal of the American College of Cardiology revealed that more women under 45 are dying of heart disease due to clogged arteries, while the death rate for men that age has leveled off.
Heart experts aren't sure what is taking place, but they think increasing rates of obesity and other risk factors are to blame for the rising rate of cardiovascular disease in young women.
"Advancements in treatment and preventive measures, such as prescribing cholesterol-lowering medications, are improving the outcomes for thousands of individuals. The problem, however, is that we still need to get constructive preventive measures in the lives of people earlier rather than later when expensive, life-saving treatment is necessary," Fey said. "There are millions of people at risk right now who will benefit from low-cost preventive care."
Preventive care often ends for American adolescents when they leave the care of a pediatrician and doesn't resume until symptoms occur later in life, he noted.
"The disease process starts early in life and steps -- many of them simple and inexpensive -- should be taken then to avoid serious medical complications later in life," Fey said.
Those action steps should include health risk assessments and early screening tests such as comprehensive blood work so top risks can be determined and controlled, he said. U.S. Preventive Medicine(R) offers proactive preventive health services at every point in the healthcare continuum of an individual's life, including The Prevention Plan (R), a groundbreaking online personalized prevention plan for individuals. The company also offers high-technology diagnostic and clinical services through their Centers for Preventive Medicine and a suite of chronic disease management tools through U.S. Care Management.
About U.S. Preventive Medicine:
U.S. Preventive Medicine(R), a privately owned company, is organizing and commercializing the market for proactive preventive health services in partnership with established hospitals and physician groups. The Company licenses its proprietary methodology, technology and branding assets to a health provider, which operates a local point-of-care -- The Center for Preventive Medicine(R) -- in a geographic territory on an exclusive basis. Individually, The Center for Preventive Medicine delivers a consistent suite of prevention services; collectively, Centers across the country form The U.S. Prevention Network.
U.S. Preventive Medicine and/or The Center for Preventive Medicine do not themselves provide physician or professional services. All physician services are provided by independent practitioners exercising independent professional medical judgment. In addition, U.S. Preventive Medicine and/or The Center for Preventive Medicine do not interfere with or regulate the private physician- patient relationship. This document neither offers for sale nor solicits offers to purchase a franchise or investment unit in a Center for Preventive Medicine or any other security.
This news release contains forward-looking statements, which may not accurately reflect our actual results of operations. Some of the information in this news release contains forward-looking statements within the meaning of the federal securities laws. Forward-looking statements typically are identified by use of terms like "may," "will," "expect," "anticipate," "estimate," and similar words, although some forward-looking statements are expressed differently. The reader should be aware that our actual results could differ materially from those contained in the forward-looking statements due to a number of factors, including insufficient capital resources, inability to compete effectively, adverse economic conditions, unanticipated difficulties in product development and inability to gain market acceptance and market share.
SOURCE U.S. Preventive Medicine